BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9166540)

  • 1. "First do no harm" also applies to cancer susceptibility testing.
    Burke W; Kahn MJ; Garber JE; Collins FS
    Cancer J Sci Am; 1996; 2(5):250-2. PubMed ID: 9166540
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic predisposition testing for breast cancer.
    Schulman JD; Stern HJ
    Cancer J Sci Am; 1996; 2(5):244-9. PubMed ID: 9166539
    [No Abstract]   [Full Text] [Related]  

  • 3. 18. Genetics of breast cancer.
    Irving M; Elmslie F; Berg J
    Int J Clin Pract; 2002 Nov; 56(9):677-82. PubMed ID: 12469982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer susceptibility genes.
    Calzone KA
    Nurs Spectr (Wash D C); 1998 Nov; 8(22):12-4; quiz 14. PubMed ID: 10542765
    [No Abstract]   [Full Text] [Related]  

  • 6. The prevention of hereditary breast cancer.
    Rodriquez E; Domchek SM
    Semin Oncol; 2007 Oct; 34(5):401-5. PubMed ID: 17920894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In familial breast or ovarian carcinoma: normal cancer prevention is not enough].
    Riem L
    MMW Fortschr Med; 2004 Apr; 146(15):12. PubMed ID: 15373015
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast cancer and the family tree. An issue for all practice settings.
    Edwards QT; Seibert D; Maradiegue A; MacDonald D; Jasperson K; Lowstuter K; Weitzel J
    Adv Nurse Pract; 2007 May; 15(5):34-41; quiz 41-2. PubMed ID: 20000211
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast & ovarian cancer. Issues in risk assessment.
    Caro SW
    Adv Nurse Pract; 1999 Aug; 7(8):26-32; quiz 33-4. PubMed ID: 10745719
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.
    Wolff TA; Wilson JE
    Am Fam Physician; 2006 Nov; 74(10):1759-60. PubMed ID: 17137007
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
    Kuschel B; Lux MP; Goecke TO; Beckmann MW
    Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predisposition testing for inherited breast cancer.
    Cummings S; Olopade O
    Oncology (Williston Park); 1998 Aug; 12(8):1227-41; discussion 1241-2. PubMed ID: 11236312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers.
    James PA; Harris M; Lindeman GJ; Mitchell G
    J Med Genet; 2008 Nov; 45(11):765-6. PubMed ID: 18978334
    [No Abstract]   [Full Text] [Related]  

  • 14. [BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer].
    Loman N
    Lakartidningen; 2004 Jun; 101(25):2172-7. PubMed ID: 15281304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ratio of female to male offspring of women tested for BRCA1 and BRCA2 mutations.
    Kotar K; Brunet JS; Møller P; Hugel L; Warner E; McLaughlin J; Wong N; Narod SA; Foulkes WD
    J Med Genet; 2004 Aug; 41(8):e103. PubMed ID: 15286163
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer. A risky business--assessing breast cancer risk.
    Levy-Lahad E; Plon SE
    Science; 2003 Oct; 302(5645):574-5. PubMed ID: 14576407
    [No Abstract]   [Full Text] [Related]  

  • 17. [Susceptibility genes of familial breast cancer in Finland].
    Nevanlinna H; Kallioniemi OP
    Duodecim; 1999; 115(21):2365-74. PubMed ID: 11973868
    [No Abstract]   [Full Text] [Related]  

  • 18. Considerations in genetic counseling for inherited breast cancer predisposition.
    Robson ME; Offit K
    Semin Radiat Oncol; 2002 Oct; 12(4):362-70. PubMed ID: 12382194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.
    Brunsvold AN; Wung SF; Merkle CJ
    J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer: genetics, risks, and strategies.
    Nogueira SM; Appling SE
    Nurs Clin North Am; 2000 Sep; 35(3):663-9. PubMed ID: 10957681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.